Halozyme Therapeutics Inc. Common Stock vs Hudbay Minerals Inc. Ordinary Shares (Canada) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Hudbay Minerals Inc. Ordinary Shares (Canada) trades at $26.07 (market cap $11.24B). The key difference: Halozyme Therapeutics Inc. Common Stock and Hudbay Minerals Inc. Ordinary Shares (Canada) are close in size by market cap, and Hudbay Minerals Inc. Ordinary Shares (Canada) pays a 0.11% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Hudbay Minerals Inc. Ordinary Shares (Canada) for 1 Days on average.
| HALO | HBM | |
|---|---|---|
Market Cap | $12.58B | $11.24B |
Volume | 2,179,278 | 4,316,374 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $31.87 |
52-Week Low | $61.63 | $14.58 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $11.30B |
Dividend Yield | — | 0.11% |
Trailing returns across standard periods
Latest headlines on both assets
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Hudbay Minerals is a mining company producing copper, gold, zinc, and other metals. Its operations are located in the Americas.
Read more on HBM →